CHRISTOPHER MARTIN: Open Payments
NPI 1396058046 · ABBEVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$58,903 in 272 payments from 17 companies in 2025. Trend: 2023 $26,805 · 2024 $35,785 · 2025 $58,903
Speaker / faculty: $45,231Food & beverage: $5,751Travel & lodging: $4,654Consulting: $2,984Education: $283
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 33 | $21,417 |
| UCB, Inc. | 42 | $17,657 |
| Lilly USA, LLC | 31 | $11,159 |
| LEO Pharma Inc. | 33 | $5,177 |
| ABBVIE INC. | 37 | $978 |
| Regeneron Healthcare Solutions, Inc. | 9 | $464 |
| PFIZER INC. | 18 | $393 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $315 |
| Amgen Inc. | 10 | $245 |
| E.R. Squibb & Sons, L.L.C. | 11 | $235 |
Products named: TREMFYA, Bimzelx, EBGLYSS, ANZUPGO, ADBRY, DUPIXENT, RINVOQ, SKYRIZI.
Industry payments across SC — which companies pay providers there.
